尿激酶、抵克力得治疗老年人高黏血症的对比研究

首都医科大学学报 ›› 2001, Vol. 22 ›› Issue (2): 138-140.

尿激酶、抵克力得治疗老年人高黏血症的对比研究

杜晓红, 曾谦, 刘洁凡

温州医学院第一附属医院老干部病房

收稿日期:2001-04-18 修回日期:1900-01-01 出版日期:2001-04-15 发布日期:2001-04-15

Effects of Urokinase and Ticlopidine on Blood Viscosity Parameters in Elderly Patients

Du Xiaohong, Zeng Qian, Liu Jiefan

Department of Elderly, the First Affiliated Hospital, Wenzhou Medical College

Received:2001-04-18 Revised:1900-01-01 Online:2001-04-15 Published:2001-04-15

摘要/Abstract

摘要：

为比较尿激酶、抵克力得对高黏血症的治疗作用,将46例老年患者分为尿激酶(24例)、抵克力得(22例)2组.尿激酶组静脉给尿激酶25万U/d,10d为1个疗程,抵克力得组口服抵克力得0.25g/d,20d为1个疗程.分别于单个疗程前后检测血液流变学指标.结果:2组血液黏度均下降,但作用环节不同.提示:2种药物均可治疗老年人高黏血症,并宜根据具体血液流变学指标合理选药.

关键词: 尿激酶, 抵克力得, 高黏血症

Abstract:

To determine the effects of urokinase and ticlopidine on blood viscosity parameters in the elderly patients. Fouty-six patients were randomly divided into two groups. Twenty-four patients were treated by vein with urokinase at dose of 250 000 U/d, 22 patients were treated with ticlopidine at dose of 0.25 g/d. And blood viscosity paramoters were measured. Both urokinase and ticlopidine could decrease blood viscosity, but have different effect on blood viscosity parameters. The two drugs have different effects on treating blood hyperviscosity. They should be used according to blood viscosity parameters.

Key words: urokinase, ticlopidine, hyperviscosity

中图分类号:

R592

杜晓红;曾谦;刘洁凡. 尿激酶、抵克力得治疗老年人高黏血症的对比研究[J]. 首都医科大学学报, 2001, 22(2): 138-140.

Du Xiaohong;Zeng Qian;Liu Jiefan . Effects of Urokinase and Ticlopidine on Blood Viscosity Parameters in Elderly Patients[J]. Journal of Capital Medical University, 2001, 22(2): 138-140.

[1]	田轩, 王盛, 刘建龙, 陈忠. 下腔静脉滤器血栓形成局部置管溶栓与外周静脉溶栓治疗的比较[J]. 首都医科大学学报, 2015, 36(1): 53-57.
[2]	向绍通;徐书雯;李东风. 迟发性阿尔茨海默病患者血清尿激酶型纤溶酶原激活因子浓度的测定及其意义[J]. 首都医科大学学报, 2012, 33(1): 103-106.
[3]	向绍通;徐书雯;李东风. 尿激酶型纤溶酶原激活因子基因P141L多态性与迟发性阿尔茨海默病的关系[J]. 首都医科大学学报, 2008, 29(3): 278-282.
[4]	刘毅;王辰;杨媛华;庞宝森;黄秀霞;辛萍;侯晓莉;王军. 重组尿激酶原对人肺动脉内皮细胞u-PA系统的影响[J]. 首都医科大学学报, 2007, 28(4): 467-470.
[5]	禹雪梅;刘晓勇;王雅杰;丁利. 血清VEGF、VEGF C和uPAR水平与口腔鳞状细胞癌的关系[J]. 首都医科大学学报, 2007, 28(2): 158-161.
[6]	毛文苹;王辰;庞宝森;欧阳松云;杨媛华;代华平. 肺血栓栓塞症大鼠血浆尿激酶型纤溶酶原激活物及其受体的动态变化及其意义[J]. 首都医科大学学报, 2006, 27(1): 5-8.
[7]	许骥;华琦;刘力松;万云高;李东宝;胥照平;姜燕;杨旭;李天德;胡大一;刘荣坤;杨峥. 重组人尿激酶原与尿激酶对急性心肌梗死患者纤溶系统影响的比较[J]. 首都医科大学学报, 2005, 26(2): 132-135.
[8]	温祥云;温嘉. 应用结合于内皮细胞的尿激酶预防血栓形成[J]. 首都医科大学学报, 1996, 17(3): 173-176.